Description
THIS REPORT:
Provides a thorough evaluation of the market for influenza vaccines, therapeutics, and diagnostics
Offers a global analysis, with emphasis on U.S. data, and a fiv...(more)
Description
STUDY OVERVIEW
Today's market driven environment has made performance assessment of managed market account executives complex and critical. Best Practices, LLC has conducted this in-depth stud...(more)
Description
The Manufacturing and Supply Agreements in Pharma, Biotech and Diagnostics, 2nd edition report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements ...(more)
Description
Introduction
Drug therapies for immune disorders span an enormous price range—from a few cents per day to tens of thousands
of dollars per year. Not surprisingly, payers impose restricti...(more)
Description
The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the wor...(more)
Description
REPORT HIGHTLIGHTS
Description
Introduction
Targeted cancer therapies have achieved phenomenal growth, and many MAb-based immunotherapies are blockbusters
or mega-blockbusters. This market success is due not only to ...(more)
Description
The Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered int...(more)
Description
The report provides a detailed understand and analysis of how and why companies enter co-promotion and co-marketing deals. The majority of deals are multicomponent whereby the licensor retains either ...(more)
Description
In BMI’s updated Business Environment Rankings (BER) for Q109, Peru has slipped from second-last tolast position in the Americas matrix, thus remaining one of the least attractive pharmaceutical...(more)
Description
This benchmark research study assessed Marketing Staffing and Activity versus growth and margin rates across three segments - Branded Bio-Pharma Rx Products, Medical Devices, and Generic Products.
...(more)
Description
Introduction
This databook provides insight into the top 10 companies in France life sciences industry in terms of their estimated IT spend.
Scope
Description
This report analyzes the global market for Cancer Therapies in US$ Billion. The specific product segments analyzed are Chemotherapy, Targeted Therapy, Hormonal Therapy, and Immunotherapy. Annual forec...(more)
Description
The Chinese Hospital Pharmaceutical Market Outlook to 2014’ provides comprehensive coverage of the Chinese pharmaceutical market, reviewing the market structure, pricing and regulation, and incl...(more)
Description
Euromonitor International's Eye Care in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowi...(more)
Description
Euromonitor International's Wound Treatments in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008...(more)
Description
ImmunoGen, Inc. develops targeted anticancer biopharmaceuticals. The Company`s proprietary TAP technology uses tumor-targeting antibodies to deliver a potent cell-killing agent specifically to cancer ...(more)
Description
The Slovakian pharmaceutical market reached EUR1.52bn (US$2.04bn) with per-capita expenditure ofUS$378 in 2008. Drug market expenditure is expected to drop to EUR1.43bn (US$2.02bn) in 2009, withper-ca...(more)
Description
Introduction
The cancer therapies market offers a high level of commercial reward to a handful of companies including Roche, Sanofi-Aventis, AstraZeneca, Novartis and Eli Lilly. Cancer ...(more)
Description
BMI calculates Germany’s pharmaceutical expenditure to have been EUR37.3bn (US$55.0bn) in 2008.By 2013, we expect the total amount spent on prescription and OTC medicines to have reached a value...(more)
Description
In BMI’s Business Environment Rankings (BER) for Q409, France remains ranked 3rd out of the 9Western European markets surveyed. Despite its unwavering focus on cost-containment, the country&rsqu...(more)
Description
BMI calculates that South Korea’s pharmaceutical market was worth around KRW10,700bn (US$9.9bn)in 2008. Between 2008 and 2013, we forecast a compound annual growth rate (CAGR) of 3.5% in localcu...(more)
Description
BMI forecasts that the Czech drug market will grow at a compound annual growth rate (CAGR) of 4.8%over the 2008-2013 period. Although this represents a fall on the 8.1% growth and 13.9% growthwitnesse...(more)
Description This report comprises defined and up to date development strategies for 409 protein kinase drugs (990 projects) within the portfolio of 160 investigators, from Ceased to Marketed. The report extens...(more)
Description
The Czech Republic has one of the most developed and technologically advanced pharmaceutical marketsin Central & Eastern Europe (CEE). Despite the impact of the economic downturn, BMI believes thatCze...(more)
Description Ion channels represent a significant opportunity to address an underexploited class of therapeutic targets. Nearly 150 novel ion channel modulators are reported to be in clinical development. This ...(more)
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
